Johnson & Johnson (JNJ)
221.24
-1.27
(-0.57%)
USD |
NYSE |
May 08, 16:00
221.25
+0.01
(+0.00%)
After-Hours: 20:00
Johnson & Johnson EPS Diluted (Quarterly) : 2.141 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Biogen, Inc. | 2.153 |
| Gilead Sciences, Inc. | 1.742 |
| Protagonist Therapeutics, Inc. | 0.0537 |
| Moderna, Inc. | -3.40 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.235B |
| Revenue (Quarterly) | 24.07B |
| Total Expenses (Quarterly) | 18.83B |
| Enterprise Value | 568.57B |
| Gross Profit Margin (Quarterly) | 66.91% |
| Profit Margin (Quarterly) | 21.75% |
| Earnings Yield | 3.91% |
| Operating Earnings Yield | 4.81% |
| Normalized Earnings Yield | 4.207 |